Randall Hudspeth, PhD, MS, APRN-CNP, FAANP, previews his presentation for the American Association of Nurse Practitioners 2025 National Conference on safe opioid prescribing.
06/17/2025
ACP Internal Medicine Meeting 2025 Video Interview
ACP Internal Medicine Meeting 2025 Video Interview
From GLP-1s to access deserts, Irl B. Hirsch, MD, MACP highlights key topics from his ACP Internal Medicine Meeting presentation on 2024's top endocrine studies and urgent care challenges.
In this video, Cecile Feldman, DMD, MBA, discusses her recent study demonstrating that ibuprofen and acetaminophen are more effective than opioids for managing post-dental surgery pain. She highlights the...
In his PUPC 2024 session, "Using the Most Recent Safe Opioid Prescribing and Alternative Therapy Guidelines in Primary Care," Randall Hudspeth, PhD, MBA, MS, APRN-CNP, FRE, FAANP, provided an overview of...
In this video, Steven Feldman, MD, PhD, provides a wrap-up of the session “Digging Deeper: Medication Adherence” during our Practical Updates in Primary Care 2023 Virtual Series, including a possible cause...
In this video, Monica Gandhi, MD, MPH, discusses the results of her team's recent study which examined the use of long-acting antiretroviral therapy (LA-ART) in individuals with HIV with viremia, which is...
In this video, Steven Feldman, MD, PhD, provides a preview of the session “Digging Deeper: Medication Adherence” during our Practical Updates in Primary Care 2023 Virtual Series, including reasons patients...
In this video, Michael Bloch, MD, discusses a guide for primary care physicians to make a prompt diagnosis and treat patients with pulmonary arterial hypertension. He spoke on this topic at the Practical...
In this video, Michael Bloch, MD, discusses identifying and treating patients with pulmonary arterial hypertension. He spoke on this topic at the Practical Updates for Primary Care 2021 Virtual Series.
...
In this video, Antonio Anzueto, MD, talks about the next steps in his research into treatment options for patients with symptomatic COPD who are at high risk of exacerbations.
